- About About
-
Medical
Medical
Medical Patient Resources Cannabis Care Certification Patient's Guide to Medical Cannabis Patient's Guide to CBD Talking to your doctor Become a Legal Medical Marijuana Patient The Medical Cannabis Patient’s Guide for U.S. Travel Guide to Using Medical Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Arthritis and Medical Cannabis Cancer and Medical Cannabis Chronic Pain and Medical Cannabis Gastrointestinal Disorders and Medical Cannabis HIV/AIDS and Medical Cannabis Movement Disorders and Medical Cannabis Multiple Sclerosis and Medical Cannabis Aging and Medical Cannabis Veterans and Medical Cannabis Medical Marijuana Conditions in Your Area Growing Cannabis Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources Medical Cannabis Continuing Medical Education (CME) Cannabis Safety Medical Cannabis Research
- Legal Legal
-
Advocacy
Advocacy
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
-
Policy
Policy
Policy Policy Positions Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Data Quality Act Briefs Fact Sheet on ASA's Data Quality Act Petition to HHS ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2021 State of the States Cannabis and Cannabis Resin- Critical Review Preparation Document Medical Cannabis in America
- News News
- Join Join
-
-
Congress Votes to Extend Rohrabacher-Farr Through April
On Friday, the U.S. Senate approved H.R. 2028, a continuing resolution that will fund the federal government through April 28, 2017. The House approved the bill earlier on Thursday. The continuing resolution includes the Rohrabacher-Farr language from last year's Department of Justice's spending package, thereby keeping the protection in place for another four months before Congress must consider it again.
The Rohrabacher-Farr amendment is arguably the most important current federal protection for medical cannabis patients and others abiding by state medical cannabis laws. The amendment has been upheld in several federal cases, most prominently in U.S. vs. McIntosh. In that decision, the judge held that prosecutions against those claiming to be in compliance with state medical cannabis laws cannot proceed unless the federal government could prove there was a violation of state law. However, the judge also said that the protection only is valid if the amendment remains in effect.
With the appointment of Senator Jeff Sessions (R-AL) to be the next Attorney General, the Rohrabacher-Farr amendment could be more important than ever before. The combination of the Rohrabacher-Farr amendment along with the 2013 Cole Memo urging U.S. Attorneys to deprioritize prosecuting against those obeying state cannabis laws have been successful in substantially reducing the number of raids against dispensaries and cultivators, Sessions could repeal the Cole Memo guidance at any point. The Rohrabacher-Farr amendment is binding law, although it must be reauthorized every year.
That means the "ceasefire" against patients has been extended through April, but patient advocates will need to work to ensure that provision makes it way into the next the appropriations bill. Congress will likely debate and vote on the next appropriations bill late April, which means that you can lobby your Congressional offices directly at ASA's 2017 Unity Conference and Lobby Day, April 7-11.
Share